{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T17:44:19Z","timestamp":1778867059933,"version":"3.51.4"},"reference-count":44,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1016\/j.taap.2009.07.014","type":"journal-article","created":{"date-parts":[[2009,7,23]],"date-time":"2009-07-23T10:09:18Z","timestamp":1248343758000},"page":"99-107","source":"Crossref","is-referenced-by-count":14,"title":["Synergistic acceleration of thyroid hormone degradation by phenobarbital and the PPAR\u03b1 agonist WY14643 in rat hepatocytes"],"prefix":"10.1016","volume":"240","author":[{"given":"N.","family":"Wieneke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Neusch\u00e4fer-Rube","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.M.","family":"Bode","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Kuna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Andres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"L.C.","family":"Carnevali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.I.","family":"Hirsch-Ernst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.P.","family":"P\u00fcschel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2009.07.014_bib1","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1006\/bbrc.1993.1151","article-title":"Regulation of fibronectin mRNA expression in primary hepatocytes in response to EGF and phenobarbital","volume":"190","author":"Aubrecht","year":"1993","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.taap.2009.07.014_bib2","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/0003-2697(91)90412-M","article-title":"Continuous fluorometric assay of phenol sulfotransferase","volume":"197","author":"Beckmann","year":"1991","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.taap.2009.07.014_bib3","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s00228-005-0056-0","article-title":"Alteration of thyroid hormone homeostasis by antiepileptic drugs in humans: involvement of glucuronosyltransferase induction","volume":"61","author":"Benedetti","year":"2005","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.taap.2009.07.014_bib4","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1210\/er.23.1.38","article-title":"Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases","volume":"23","author":"Bianco","year":"2002","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.taap.2009.07.014_bib5","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.pediatrneurol.2007.07.003","article-title":"Evolution of subclinical hypothyroidism in children treated with antiepileptic drugs","volume":"37","author":"Castro-Gago","year":"2007","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.taap.2009.07.014_bib6","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1124\/dmd.105.003988","article-title":"Regulation of mouse organic anion-transporting polypeptides (Oatps) in liver by prototypical microsomal enzyme inducers that activate distinct transcription factor pathways","volume":"33","author":"Cheng","year":"2005","journal-title":"Drug. Metab. Dispos."},{"key":"10.1016\/j.taap.2009.07.014_bib7","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/0003-2697(87)90021-2","article-title":"Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction","volume":"162","author":"Chomczynski","year":"1987","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.taap.2009.07.014_bib8","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/S0026-895X(24)12047-0","article-title":"A highly sensitive fluorescent microplate method for the determination of UDP-glucuronosyl transferase activity in tissues and placental cell lines","volume":"28","author":"Collier","year":"2000","journal-title":"Drug. Metab. Dispos."},{"key":"10.1016\/j.taap.2009.07.014_bib9","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/s00204-004-0644-2","article-title":"Evaluation of mechanisms inducing thyroid toxicity and the ability of the enhanced OECD Test Guideline 407 to detect these changes","volume":"79","author":"Cunha","year":"2005","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.taap.2009.07.014_bib10","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1111\/j.1528-1157.1999.tb01595.x","article-title":"Long-term treatment of children with epilepsy with valproate or carbamazepine may cause subclinical hypothyroidism","volume":"40","author":"Eiris-Punal","year":"1999","journal-title":"Epilepsia."},{"key":"10.1016\/j.taap.2009.07.014_bib11","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.taap.2006.01.009","article-title":"A mode of action for induction of thyroid gland tumors by pyrethrins in the rat","volume":"214","author":"Finch","year":"2006","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2009.07.014_bib12","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1210\/jc.85.8.2879","article-title":"Characterization of the uridine diphosphate-glucuronosyltransferase-catalyzing thyroid hormone glucuronidation in man","volume":"85","author":"Findlay","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.taap.2009.07.014_bib13","doi-asserted-by":"crossref","first-page":"489","DOI":"10.2460\/javma.1999.215.04.489","article-title":"Effects of phenobarbital treatment on serum thyroxine and thyroid-stimulating hormone concentrations in epileptic dogs","volume":"215","author":"Gaskill","year":"1999","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"10.1016\/j.taap.2009.07.014_bib14","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s11154-007-9049-x","article-title":"Perturbed nuclear receptor signaling by environmental obesogens as emerging factors in the obesity crisis","volume":"8","author":"Grun","year":"2007","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"10.1016\/j.taap.2009.07.014_bib15","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1124\/mol.59.6.1402","article-title":"Repression of phenobarbital-dependent CYP2B1 mRNA induction by reactive oxygen species in primary rat hepatocyte cultures","volume":"59","author":"Hirsch-Ernst","year":"2001","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.taap.2009.07.014_bib16","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1093\/toxsci\/55.1.78","article-title":"Differential effects of microsomal enzyme inducers on in vitro thyroxine (T(4)) and triiodothyronine (T(3)) glucuronidation","volume":"55","author":"Hood","year":"2000","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.taap.2009.07.014_bib17","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s00204-006-0141-x","article-title":"Induction of peroxisome proliferator-activated receptor alpha (PPARalpha)-related enzymes by di(2-ethylhexyl) phthalate (DEHP) treatment in mice and rats, but not marmosets","volume":"81","author":"Ito","year":"2007","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.taap.2009.07.014_bib18","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1089\/thy.2005.15.757","article-title":"Thyroid hormone transporters in health and disease","volume":"15","author":"Jansen","year":"2005","journal-title":"Thyroid."},{"key":"10.1016\/j.taap.2009.07.014_bib19","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1743-7075-3-25","article-title":"Energy expenditure during overfeeding","volume":"3","author":"Joosen","year":"2006","journal-title":"Nutr. Metab. (Lond)."},{"key":"10.1016\/j.taap.2009.07.014_bib20","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1124\/dmd.106.011536","article-title":"Effects of alterations in CAR on bilirubin detoxification in mouse collagen-induced arthritis","volume":"35","author":"Kawase","year":"2007","journal-title":"Drug. Metab. Dispos."},{"key":"10.1016\/j.taap.2009.07.014_bib21","doi-asserted-by":"crossref","first-page":"8","DOI":"10.2133\/dmpk.23.8","article-title":"The roles of nuclear receptors CAR and PXR in hepatic energy metabolism","volume":"23","author":"Konno","year":"2008","journal-title":"Drug. Metab. Pharmacokinet."},{"key":"10.1016\/j.taap.2009.07.014_bib22","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1056\/NEJM199503093321001","article-title":"Changes in energy expenditure resulting from altered body weight","volume":"332","author":"Leibel","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.taap.2009.07.014_bib23","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2009.07.014_bib24","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0003-9861(85)90138-9","article-title":"Dealkylation of pentoxyresorufin: a rapid and sensitive assay for measuring induction of cytochrome(s) P-450 by phenobarbital and other xenobiotics in the rat","volume":"238","author":"Lubet","year":"1985","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.taap.2009.07.014_bib25","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1124\/dmd.106.011379","article-title":"Clofibrate increases hepatic triiodothyronine (T3)-and thyroxine (T4)-glucuronosyltransferase activities and lowers plasma T3 and T4 concentrations in pigs","volume":"34","author":"Luci","year":"2006","journal-title":"Drug. Metab. Dispos."},{"key":"10.1016\/j.taap.2009.07.014_bib26","doi-asserted-by":"crossref","first-page":"19832","DOI":"10.1074\/jbc.M313601200","article-title":"The nuclear receptor CAR is a regulator of thyroid hormone metabolism during caloric restriction","volume":"279","author":"Maglich","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2009.07.014_bib27","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1006\/taap.1999.8809","article-title":"trans-Activation of PPARalpha and PPARgamma by structurally diverse environmental chemicals","volume":"161","author":"Maloney","year":"1999","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2009.07.014_bib28","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0378-4274(92)90213-4","article-title":"Thyroid gland neoplasia: non-genotoxic mechanisms","volume":"65","author":"McClain","year":"1992","journal-title":"Toxico. Lett."},{"key":"10.1016\/j.taap.2009.07.014_bib29","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1124\/jpet.105.093765","article-title":"Induction of hepatic transporters multidrug resistance-associated proteins (Mrp) 3 and 4 by clofibrate is regulated by peroxisome proliferator-activated receptor alpha","volume":"317","author":"Moffit","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.taap.2009.07.014_bib30","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.1016\/S0021-9258(19)83611-6","article-title":"Phenobarbital induction of rat liver cytochromes P-450b and P-450e. Quantitation of specific RNAs by hybridization to synthetic oligodeoxyribonucleotide probes","volume":"260","author":"Omiecinski","year":"1985","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2009.07.014_bib31","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/j.1432-1033.1993.tb18468.x","article-title":"Glycogenolytic and antiglycogenolytic prostaglandin E2 actions in rat hepatocytes are mediated via different signalling pathways","volume":"218","author":"P\u00fcschel","year":"1993","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.taap.2009.07.014_bib32","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1210\/en.2004-1350","article-title":"Role of the constitutive androstane receptor in xenobiotic-induced thyroid hormone metabolism","volume":"146","author":"Qatanani","year":"2005","journal-title":"Endocrinology."},{"key":"10.1016\/j.taap.2009.07.014_bib33","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.taap.2007.09.015","article-title":"Possible mechanisms of thyroid hormone disruption in mice by BDE 47, a major polybrominated diphenyl ether congener","volume":"226","author":"Richardson","year":"2008","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2009.07.014_bib34","doi-asserted-by":"crossref","first-page":"731","DOI":"10.3109\/00365517809104880","article-title":"Effect of carbamazepine, phenytoin and phenobarbitone on serum levels of thyroid hormones and thyrotropin in humans","volume":"38","author":"Rootwelt","year":"1978","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.taap.2009.07.014_bib35","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1053\/jhep.2001.24172","article-title":"The phenobarbital response enhancer module in the human bilirubin UDP-glucuronosyltransferase UGT1A1 gene and regulation by the nuclear receptor CAR","volume":"33","author":"Sugatani","year":"2001","journal-title":"Hepatology."},{"key":"10.1016\/j.taap.2009.07.014_bib36","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1124\/jpet.106.112706","article-title":"The nuclear receptor constitutively active\/androstane receptor regulates type 1 deiodinase and thyroid hormone activity in the regenerating mouse liver","volume":"320","author":"Tien","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.taap.2009.07.014_bib37","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1124\/dmd.107.016972","article-title":"In vitro glucuronidation of thyroxine and triiodothyronine by liver microsomes and recombinant human UDP-glucuronosyltransferases","volume":"35","author":"Tong","year":"2007","journal-title":"Drug. Metab. Dispos."},{"key":"10.1016\/j.taap.2009.07.014_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/mol.61.1.1","article-title":"Diverse roles of the nuclear orphan receptor CAR in regulating hepatic genes in response to phenobarbital","volume":"61","author":"Ueda","year":"2002","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.taap.2009.07.014_bib39","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1124\/dmd.30.3.240","article-title":"Increase in rat liver UDP-glucuronosyltransferase mRNA by microsomal enzyme inducers that enhance thyroid hormone glucuronidation","volume":"30","author":"Vansell","year":"2002","journal-title":"Drug. Metab. Dispos."},{"key":"10.1016\/j.taap.2009.07.014_bib40","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0009-2797(94)90071-X","article-title":"Role of sulfation in thyroid hormone metabolism","volume":"92","author":"Visser","year":"1994","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.taap.2009.07.014_bib41","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1210\/en.133.5.2177","article-title":"Glucuronidation of thyroid hormone in rat liver: effects of in vivo treatment with microsomal enzyme inducers and in vitro assay conditions","volume":"133","author":"Visser","year":"1993","journal-title":"Endocrinology."},{"key":"10.1016\/j.taap.2009.07.014_bib42","doi-asserted-by":"crossref","first-page":"5617","DOI":"10.1016\/j.febslet.2007.11.011","article-title":"PPARalpha-dependent induction of the energy homeostasis-regulating nuclear receptor NR1i3 (CAR) in rat hepatocytes: potential role in starvation adaptation","volume":"581","author":"Wieneke","year":"2007","journal-title":"FEBS. Lett."},{"key":"10.1016\/j.taap.2009.07.014_bib43","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/01.mjt.0000209673.01885.b0","article-title":"Preclinical development of new drugs that enhance thyroid hormone metabolism and clearance: inadequacy of using rats as an animal model for predicting human risks in an IND and NDA","volume":"13","author":"Wu","year":"2006","journal-title":"Am. J. Ther."},{"key":"10.1016\/j.taap.2009.07.014_bib44","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1442-200X.1993.tb03018.x","article-title":"Serum TH and pituitary response to thyrotropin-releasing hormone in epileptic children receiving anti-epileptic medication","volume":"35","author":"Yuksel","year":"1993","journal-title":"Acta. Paediatr. Jpn."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X0900297X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X0900297X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T09:54:51Z","timestamp":1739267691000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X0900297X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["S0041008X0900297X"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2009.07.014","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}